Abstract
Here we describe MRI and 1H MRS protocols for the investigation of animal models (mainly mice and rats) of psychiatric disorders. The introduction provides general findings from brain imaging studies in patients with psychiatric diseases and refers to general rules regarding the use of animal models in research. The methods section includes a selection of basic 9.4 T MRI and MRS protocols applicable for the investigation of animal models of psychiatric disorders (T1W, T2W, FLAIR, 1H MRS). The notes section discusses in detail a series of factors that can influence the outcome of the experiment: from animal handling, stress-triggering aspects, and experimental design-related factors to technical aspects that affect T 1 and T 2 measurements.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abou-Saleh, M. T. (2006) Neuroimaging in psychiatry: an update. J. Psychosom. Res. 61, 289–293.
Barkley, R. A., Grodzinsky, G., and DuPaul, G. J. (1992) Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J. Abnorm. Child Psychol. 20, 163–188.
Mattes, J. A. (1980) The role of frontal lobe dysfunction in childhood hyperkinesis. Compr. Psychiatry 21, 358–369.
Bush, G., Valera, E. M., and Seidman, L. J. (2005) Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry 57, 1273–1284.
Blumberg, H. P., Kaufman, J., Martin, A., Whiteman, R., Zhang, J. H., Gore, J. C., Charney, D. S., Krystal, J. H., and Peterson, B. S. (2003) Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch. Gen. Psychiatry 60, 1201–1208.
Chang, K., Karchemskiy, A., Barnea-Goraly, N., Garrett, A., Simeonova, D. I., and Reiss, A. (2005) Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 44, 565–573.
Rosso, I. M., Killgore, W. D., Cintron, C. M., Gruber, S. A., Tohen, M., and Yurgelun-Todd, D. A. (2007) Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter. Biol. Psychiatry 61, 743–749.
Andreone, N., Tansella, M., Cerini, R., Rambaldelli, G., Versace, A., Marrella, G., Perlini, C., Dusi, N., Pelizza, L., Balestrieri, M., Barbui, C., Nose, M., Gasparini, A., and Brambilla, P. (2007) Cerebral atrophy and white matter disruption in chronic schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 257, 3–11.
Steen, R. G., Hamer, R. M., and Lieberman, J. A. (2005) Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30, 1949–1962.
Molina, V., Sanchez, J., Reig, S., Sanz, J., Benito, C., Santamarta, C., Pascau, J., Sarramea, F., Gispert, J. D., Misiego, J. M., Palomo, T., and Desco, M. (2005) N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration. Schizophr. Res. 73, 209–219.
Ohrmann, P., Siegmund, A., Suslow, T., Spitzberg, K., Kersting, A., Arolt, V., Heindel, W., and Pfleiderer, B. (2005) Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr. Res. 73, 153–157.
Abbott, C., and Bustillo, J. (2006) What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr. Opin. Psychiatry 19, 135–139.
Luders, E., Narr, K. L., Hamilton, L. S., Phillips, O. R., Thompson, P. M., Valle, J. S., Del'Homme, M., Strickland, T., McCracken, J. T., Toga, A. W., and Levitt, J. G. (2009) Decreased callosal thickness in attention-deficit/hyperactivity disorder. Biol. Psychiatry 65, 84–88.
Seidman, L. J., Valera, E. M., and Makris, N. (2005) Structural brain imaging of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57, 1263–1272.
Carrey, N. J., MacMaster, F. P., Gaudet, L., and Schmidt, M. H. (2007) Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J. Child. Adolesc. Psychopharmacol. 17, 11–17.
Sheline, Y. I., Mittler, B. L., and Mintun, M. A. (2002) The hippocampus and depression. Eur. Psychiatry 17(Suppl 3), 300–305.
Mervaala, E., Fohr, J., Kononen, M., Valkonen-Korhonen, M., Vainio, P., Partanen, K., Partanen, J., Tiihonen, J., Viinamaki, H., Karjalainen, A. K., and Lehtonen, J. (2000) Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol. Med. 30, 117–125.
Vakili, K., Pillay, S. S., Lafer, B., Fava, M., Renshaw, P. F., Bonello-Cintron, C. M., and Yurgelun-Todd, D. A. (2000) Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol. Psychiatry 47, 1087–1090.
Brown, E. S., D, J. W., Frol, A., Bobadilla, L., Khan, D. A., Hanczyc, M., Rush, A. J., Fleckenstein, J., Babcock, E., and Cullum, C. M. (2004) Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry 55, 538–545.
Bremner, J. D. (2002) Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectr. 7, 129–130, 135–129.
Bremner, J. D., Vythilingam, M., Vermetten, E., Nazeer, A., Adil, J., Khan, S., Staib, L. H., and Charney, D. S. (2002) Reduced volume of orbitofrontal cortex in major depression. Biol. Psychiatry 51, 273–279.
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., and Charney, D. S. (2000) Hippocampal volume reduction in major depression. Am. J. Psychiatry 157, 115–118.
Krishnan, K. R., McDonald, W. M., Escalona, P. R., Doraiswamy, P. M., Na, C., Husain, M. M., Figiel, G. S., Boyko, O. B., Ellinwood, E. H., and Nemeroff, C. B. (1992) Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch. Gen. Psychiatry 49, 553–557.
Drevets, W. C., Price, J. L., Simpson, J. R., Jr., Todd, R. D., Reich, T., Vannier, M., and Raichle, M. E. (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824–827.
Hirayasu, Y., Shenton, M. E., Salisbury, D. F., Kwon, J. S., Wible, C. G., Fischer, I. A., Yurgelun-Todd, D., Zarate, C., Kikinis, R., Jolesz, F. A., and McCarley, R. W. (1999) Subgenual cingulate cortex volume in first-episode psychosis. Am. J. Psychiatry 156, 1091–1093.
Drevets, W. C. (2000) Neuroimaging studies of mood disorders. Biol. Psychiatry 48, 813–829.
Soares, J. C., and Mann, J. J. (1997) The anatomy of mood disorders – review of structural neuroimaging studies. Biol. Psychiatry 41, 86–106.
Soares, J. C., and Mann, J. J. (1997) The functional neuroanatomy of mood disorders. J. Psychiatr. Res. 31, 393–432.
Schuff, N., Neylan, T. C., Fox-Bosetti, S., Lenoci, M., Samuelson, K. W., Studholme, C., Kornak, J., Marmar, C. R., and Weiner, M. W. (2008) Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res. 162, 147–157.
Mohanakrishnan Menon, P., Nasrallah, H. A., Lyons, J. A., Scott, M. F., and Liberto, V. (2003) Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry Res. 123, 101–108.
Neylan, T. C., Schuff, N., Lenoci, M., Yehuda, R., Weiner, M. W., and Marmar, C. R. (2003) Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol. Psychiatry 54, 1118–1121.
Pollack, M. H., Jensen, J. E., Simon, N. M., Kaufman, R. E., and Renshaw, P. F. (2008) High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 739–743.
Lyoo, I. K., Yoon, S. J., Musen, G., Simonson, D. C., Weinger, K., Bolo, N., Ryan, C. M., Kim, J. E., Renshaw, P. F., and Jacobson, A. M. (2009) Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch. Gen. Psychiatry 66, 878–887.
Milne, A., MacQueen, G. M., Yucel, K., Soreni, N., and Hall, G. B. (2009) Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study. Neuroimage 47, 36–41.
Dawe, G. S., and Ratty, A. K. (2007) The chakragati mouse: a mouse model for rapid in vivo screening of antipsychotic drug candidates. Biotechnol. J. 2, 1344–1352.
Torres, G., Hallas, B. H., Gross, K. W., Spernyak, J. A., and Horowitz, J. M. (2008) Magnetic resonance imaging and spectroscopy in a mouse model of schizophrenia. Brain Res. Bull. 75, 556–561.
Luby, E. D., Cohen, B. D., Rosenbaum, G., Gottlieb, J. S., and Kelley, R. (1959) Study of a new schizophrenomimetic drug; sernyl. AMA Arch. Neurol. Psychiatry 81, 363–369.
Allen, R. M., and Young, S. J. (1978) Phencyclidine-induced psychosis. Am. J. Psychiatry 135, 1081–1084.
Javitt, D. C., and Zukin, S. R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301–1308.
Reynolds, L. M., Cochran, S. M., Morris, B. J., Pratt, J. A., and Reynolds, G. P. (2005) Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophr. Res. 73, 147–152.
Kalisch, R., Schubert, M., Jacob, W., Kessler, M. S., Hemauer, R., Wigger, A., Landgraf, R., and Auer, D. P. (2006) Anxiety and hippocampus volume in the rat. Neuropsychopharmacology 31, 925–932.
Schubert, M. I., Kalisch, R., Sotiropoulos, I., Catania, C., Sousa, N., Almeida, O. F., and Auer, D. P. (2008) Effects of altered corticosteroid milieu on rat hippocampal neurochemistry and structure – an in vivo magnetic resonance spectroscopy and imaging study. J. Psychiatr. Res. 42, 902–912.
Sartorius, A., Mahlstedt, M. M., Vollmayr, B., Henn, F. A., and Ende, G. (2007) Elevated spectroscopic glutamate/gamma-amino butyric acid in rats bred for learned helplessness. Neuroreport 18, 1469–1473.
Tkac, I., Henry, P. G., Andersen, P., Keene, C. D., Low, W. C., and Gruetter, R. (2004) Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T. Magn. Reson. Med. 52, 478–484.
Donovan, J., and Brown, P. (2004) Handling and restraint. Curr. Protoc. Neurosci. Appendix 4, Appendix 4D.
Pham, K., Nacher, J., Hof, P. R., and McEwen, B. S. (2003) Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci. 17, 879–886.
Chen, Y. C., Galpern, W. R., Brownell, A. L., Matthews, R. T., Bogdanov, M., Isacson, O., Keltner, J. R., Beal, M. F., Rosen, B. R., and Jenkins, B. G. (1997) Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn. Reson. Med. 38, 389–398.
Karlik, S. J., Fuller, J., and Gelb, A. W. (1986) Anesthetics change tissue proton NMR relaxation. Acta Radiol. Suppl. 369, 500–502.
Willis, C. K., Quinn, R. P., McDonell, W. M., Gati, J., Parent, J., and Nicolle, D. (2001) Functional MRI as a tool to assess vision in dogs: the optimal anesthetic. Vet. Ophthalmol. 4, 243–253.
Weber, R., Ramos-Cabrer, P., Wiedermann, D., van Camp, N., and Hoehn, M. (2006) A fully noninvasive and robust experimental protocol for longitudinal fMRI studies in the rat. Neuroimage 29, 1303–1310.
Pawson, P., and Forsyth, S. (2008) Anaesthetic agents. In Maddison, J. E., Page, S. W., and Church, D. B. (Eds.), Small Animal Clinical Pharmacology, 2nd ed., pp. 83–112. Saunders, Edinburgh.
Sicard, K., Shen, Q., Brevard, M. E., Sullivan, R., Ferris, C. F., King, J. A., and Duong, T. Q. (2003) Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J. Cereb. Blood Flow Metab. 23, 472–481.
Brevard, M. E., Duong, T. Q., King, J. A., and Ferris, C. F. (2003) Changes in MRI signal intensity during hypercapnic challenge under conscious and anesthetized conditions. Magn. Reson. Imaging. 21, 995–1001.
Martin, C., Jones, M., Martindale, J., and Mayhew, J. (2006) Haemodynamic and neural responses to hypercapnia in the awake rat. Eur. J. Neurosci. 24, 2601–2610.
Martin, C., Martindale, J., Berwick, J., and Mayhew, J. (2006) Investigating neural-hemodynamic coupling and the hemodynamic response function in the awake rat. Neuroimage 32, 33–48.
Zhao, F., Jin, T., Wang, P., and Kim, S. G. (2007) Improved spatial localization of post-stimulus BOLD undershoot relative to positive BOLD. Neuroimage 34, 1084–1092.
Zhao, F., Jin, T., Wang, P., and Kim, S. G. (2007) Isoflurane anesthesia effect in functional imaging studies. Neuroimage 38, 3–4.
Dashti, M., Geso, M., and Williams, J. (2005) The effects of anaesthesia on cortical stimulation in rats: a functional MRI study. Australas. Phys. Eng. Sci. Med. 28, 21–25.
Silverman, J., and Muir, W. W., 3rd. (1993) A review of laboratory animal anesthesia with chloral hydrate and chloralose. Lab. Anim. Sci. 43, 210–216.
Sommers, M. G., van Egmond, J., Booij, L. H., and Heerschap, A. (2009) Isoflurane anesthesia is a valuable alternative for alpha-chloralose anesthesia in the forepaw stimulation model in rats. NMR Biomed. 22, 414–418.
Braw, Y., Malkesman, O., Merenlender, A., Dagan, M., Bercovich, A., Lavi-Avnon, Y., and Weller, A. (2009) Divergent maternal behavioral patterns in two genetic animal models of depression. Physiol. Behav. 96, 209–217.
Spring, S., Lerch, J. P., and Henkelman, R. M. (2007) Sexual dimorphism revealed in the structure of the mouse brain using three-dimensional magnetic resonance imaging. Neuroimage 35, 1424–1433.
Berl, S., Nunez, R., Colon, A. D., and Clarke, D. D. (1983) Acetylation of synaptosomal protein: inhibition by veratridine. J. Neurochem. 40, 176–183.
Brenner, E., Sonnewald, U., Schweitzer, A., Andrieux, A., and Nehlig, A. (2007) Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia. J. Neurosci. Res. 85, 3487–3493.
Sibson, N. R., Mason, G. F., Shen, J., Cline, G. W., Herskovits, A. Z., Wall, J. E., Behar, K. L., Rothman, D. L., and Shulman, R. G. (2001) In vivo (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during. J. Neurochem. 76, 975–989.
Lebon, V., Petersen, K. F., Cline, G. W., Shen, J., Mason, G. F., Dufour, S., Behar, K. L., Shulman, G. I., and Rothman, D. L. (2002) Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J. Neurosci. 22, 1523–1531.
Shulman, R. G., Rothman, D. L., Behar, K. L., and Hyder, F. (2004) Energetic basis of brain activity: implications for neuroimaging. Trends. Neurosci. 27, 489–495.
Sonnewald, U., and Kondziella, D. (2003) Neuronal glial interaction in different neurological diseases studied by ex vivo 13C NMR spectroscopy. NMR Biomed. 16, 424–429.
Taylor, A., McLean, M., Morris, P., and Bachelard, H. (1996) Approaches to studies on neuronal/glial relationships by 13C-MRS analysis. Dev. Neurosci. 18, 434–442.
Rodrigues, T. B., and Cerdan, S. (2005) A fast and sensitive 1H NMR method to measure the turnover of the H2 hydrogen of lactate. Magn. Reson. Med. 54, 1014–1019.
Meric, P., Autret, G., Doan, B. T., Gillet, B., Sebrie, C., and Beloeil, J. C. (2004) In vivo 2D magnetic resonance spectroscopy of small animals. MAGMA 17, 317–338.
Braakman, N., Oerther, T., de Groot, H. J., and Alia, A. (2008) High resolution localized two-dimensional MR spectroscopy in mouse brain in vivo. Magn. Reson. Med. 60, 449–456.
Kundel, H. L., Schlakman, B., Joseph, P. M., Fishman, J. E., and Summers, R. (1986) Water content and NMR relaxation time gradients in the rabbit kidney. Invest. Radiol. 21, 12–17.
Ottenweller, J. E., Meier, A. H., Russo, A. C., and Frenzke, M. E. (1979) Circadian rhythms of plasma corticosterone binding activity in the rat and the mouse. Acta Endocrinol. (Copenh) 91, 150–157.
Duong, T. Q. (2007) Cerebral blood flow and BOLD fMRI responses to hypoxia in awake and anesthetized rats. Brain Res. 1135, 186–194.
Kiryu, S., Inoue, Y., Watanabe, M., Izawa, K., Shimada, M., Tojo, A., Yoshikawa, K., and Ohtomo, K. (2009) Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine. Magn. Reson. Imaging. 27, 101–107.
Narciso, S. P., Nadziejko, E., Chen, L. C., Gordon, T., and Nadziejko, C. (2003) Adaptation to stress induced by restraining rats and mice in nose-only inhalation holders. Inhal. Toxicol. 15, 1133–1143.
Harris, R. B., Gu, H., Mitchell, T. D., Endale, L., Russo, M., and Ryan, D. H. (2004) Increased glucocorticoid response to a novel stress in rats that have been restrained. Physiol. Behav. 81, 557–568.
Dunn, A. J., and Swiergiel, A. H. (2008) Effects of acute and chronic stressors and CRF in rat and mouse tests for depression. Ann. N. Y. Acad. Sci. 1148, 118–126.
Swiergiel, A. H., Leskov, I. L., and Dunn, A. J. (2008) Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Behav. Brain Res. 186, 32–40.
Venkatesan, R., Lin, W., Gurleyik, K., He, Y. Y., Paczynski, R. P., Powers, W. J., and Hsu, C. Y. (2000) Absolute measurements of water content using magnetic resonance imaging: preliminary findings in an in vivo focal ischemic rat model. Magn. Reson. Med. 43, 146–150.
Tkác, I., Henry, P. G., Andersen, P., Keene, C. D., Low, W. C., and Gruetter, R. (2004) Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T. Magn. Reson. Med. 52, 478–484.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Poole, D.S., Oitzl, M.S., van der Weerd, L. (2011). MRI in Animal Models of Psychiatric Disorders. In: Schröder, L., Faber, C. (eds) In vivo NMR Imaging. Methods in Molecular Biology, vol 771. Humana Press. https://doi.org/10.1007/978-1-61779-219-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-61779-219-9_17
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-218-2
Online ISBN: 978-1-61779-219-9
eBook Packages: Springer Protocols